Search Results

THEIR PARENTS THOUGHT THEY WERE AFRAID OF THE DARK. THEN THESE TWINS LEARNED THE TRUTH — AND THE FIGHT TO SAVE THEIR SIGHT BEGAN

Nathan and Andre needed a game-changing gene-specific therapy. But the costs were astronomical and the parents were at a loss. Here’s how I witnessed their story go from tragic to triumphant. Twins...

DEVELOPING A NEW THERAPY FOR AGE-RELATED MACULAR DEGENERATION AND DIABETIC RETINOPATHY.

Dr. Sachdev Sidhu (University of Toronto) is a biomedical engineer with extensive experience in drug development. Dr. Sidhu established the Toronto Recombinant Antibody Centre (TRAC) which houses a state-of-the-art platform to generate...

FBC SCIENTISTS COLLABORATE TO IDENTIFY NEW GENE FOR RETINITIS PIGMENTOSA

Teamwork really does make the dream work! We are excited to share news of a Fighting Blindness Canada (FBC) funded discovery recently published in the journal Science Advances achieved through a collaboration...

INHERITED RETINAL DISEASE AWARENESS MONTH

Fighting Blindness Canada (FBC) has helped make September, Inherited Retinal Disease (IRD) Awareness Month! Over 20,000 Canadians have an IRD and for most, there are no treatments available. Join us to raise...

ANNOUNCING THE 2022 CLINICIAN-SCIENTIST EMERGING LEADER AWARDS!

Fighting Blindness Canada’s (FBC’s) Clinician Scientist Emerging Leader Awards (CSELA) were launched in 2017 to build the pipeline of ophthalmologists and optometrists who also do research. Clinician-scientists help translate laboratory research into...

RECAP FROM ARVO: THE LATEST IN VISION RESEARCH

In May, FBC attended the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Denver, Colorado for five days of learning and discussing with leaders in vision research. Here are...